Integral Diagnostics’ Major Shareholders Unveiled, Yarra Funds Takes the Lead with 6.7% Stake

Integral Diagnostics Limited has disclosed its shareholder structure, revealing that individual investors hold a substantial 58% stake in the company, while institutional investors possess 32%.

The majority ownership consists of 41%, distributed among 25 investors, with Yarra Funds Management Limited leading as the largest shareholder at 6.7%. The second and third-largest shareholders follow closely, owning approximately 6.1% and 5.5%, respectively.

Despite potential risks, such as share price fluctuations due to large-scale sell-offs, institutional investors maintain a significant presence in Integral Diagnostics. Their ongoing investments signal credibility and confidence in the company’s performance, even amid some poorly performing investments.

The company’s presence in major indices is another factor attracting institutional investors and emphasizes the importance of examining Integral Diagnostics’ historical earnings when making investment choices.

As of the second quarter of 2023, the company boasts a market capitalization of $4.32 million and revenues of $37.37 million. Revenue growth has been robust, demonstrating a quarterly increase of 49.1% for FY2023.Q2. This aligns with observations indicating that the company’s revenue has been consistently rising.

Additionally, Integral Diagnostics reports a strong gross profit margin at 60.36%. However, it is important to note the rapid depletion of cash reserves, highlighted by a negative return on assets of -59.29% in Q2 2023.

In terms of recent share performance, the company experienced a notable return with a 10.49% increase over the last week. Yet, the overall performance over the past year has not been as favorable, showing a decline of -53.27%.

For further insights and investment tips, there are additional resources available that provide more detailed information regarding Integral Diagnostics Limited.

This article was generated with the assistance of AI and reviewed by an editor.